|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84 TWD | -0.24% |
|
-2.21% | +4.35% |
| 05-21 | Ch Biotech R&D Co., Ltd. Approves the Appointments of the 4th Remuneration Committee Members | CI |
| 05-21 | CH Biotech R&D Co., Ltd. Announces Audit Committee Changes | CI |
CH Biotech R&D Co., Ltd. announced the resignation of Brent Randall Smith as natural-person director. Resume of the previous position holder: Loveland Products Canada Inc. President. Reason for the change: Individual Career Development.
Original term is July 6, 2021 to July 5, 2024. The Company received the resignation letter from the Director Brent Randall Smith on March 2, 2023 and the resignation became effective as from the date.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.35% | 266M | |
| +11.62% | 36.97B | |
| -.--% | 11.74B | |
| +25.10% | 7.75B | |
| -10.06% | 7.05B | |
| +7.53% | 6.88B | |
| -9.96% | 5.59B | |
| -11.32% | 5.24B | |
| -2.86% | 5.14B | |
| +28.14% | 5.03B |
CH BIOTECH R&D CO., LTD. 
